A B S TRA CT Peripheral blood lymphocytes from 23 patients with active systemic lupus erythematosus (SLE) were serially studied. Changes in bone marrow-derived lymphocytes (B cells), as measured by surface Ig receptors and C3 receptors, and in thymus-derived cells (T cells) measured by rabbit T-cell-specific antiserum and E-binding techniques, were correlated with fluctuations in clinical disease activity and treatment. In normal controls B-and T-cell percentages remained relatively stable, although the situation in SLE was much more labile. A relative and absolute decrease in T lymphocytes and cells bearing a receptor for C3 was found in active lupus.
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l Abbreviations used in this paper: B cells, bone marrowderived lymphocytes; CLL, chronic lymphatic leukemia; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; T cells, thymus-derived lymphocytes. munity (7) (8) (9) (10) (11) . Previous studies from several laboratories (12) (13) (14) (15) (16) have indicated the presence of lymphocytotoxic antibodies among patients with connective tissue diseases particularly individuals with SLE. We have observed that cytotoxic antibodies in sera of patients with SLE have relative specificity for T cells (17) . Mellors, Shirai, Toshikazo, and Yashiki (18, 19) have recorded the presence of similar thymocyte-specific lymphocytotoxic antibodies in New Zealand Black (NZB) mice. In addition, certain patients with active RA show what appears to be a decreased proportion of peripheral blood T cells and an increase in the fraction of null cells, that is cells that cannot readily be classified as T cells or B cells using immunofluorescent techniques (20, 21) . Again similar findings have been recorded (22, 23) during the development of the naturally evolving lupus-like syndrome in NZB mice.
Besides surface Ig markers characteristic of B cells and the so-called 0-marker associated with T cells (7, 8) , two other markers have been described that may be important in evaluating subtle alterations in lymphocytes. B cells bear surface receptors for the third component of complement (C3) in addition to their Ig receptor molecules (24, 25) whereas T cells form rosettes with unsensitized sheep erythrocytes (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . The present work reports a sequential study of peripheral blood lymphocytes among patients with SLE with particular emphasis on changes in T-to B-cell ratios as correlated with fluctuations in clinical disease activity. Two markers were used to determine both types of lymphocytes.
METHODS
Patients studied. Serial studies were performed in 23 SLE patients followed in the lupus clinic at Bernalillo County Medical Center. These patients had been diagnosed as active SLE on the basis of strongly positive LE preps plus characteristic multisystem involvement using criteria recently established by the American Rheumatism Association (29 (25, 30) . B cells were enumerated using direct immunofluorescence and fluorescein-conjugated antiIg antibodies isolated and purified as previously described from immunoabsorbent columns (1, 4, 25 (26) and several other groups (27, 28 In an attempt to correlate the percent of T and B lymphocytes in the peripheral blood with disease activity and/or treatment, serial determinations were performed on 23 patients over a 3-15 mo period. 12 normal individuals were also studied serially to provide control data on the stability of the four lymphocyte markers. Table III . Standard deviation within serially studied normal individuals for E binding, and B cells by anti-Ig sera or EAC3 rosettes was less than 5%. A somewhat larger deviation of 13.3% was recorded for the percent of lymphocytes reactive with anti-T-cell serum within normal individuals. The standard deviation Fig. 3 . G. E. (Fig. 3A) reacting with the three anti-Ig sera. Whereas the drop in percent T cells in patient G. E. occurred while she was receiving a stable low dose of prednisone, the decrease in percent T cells noted in patient L. 0. (Fig. 3B) Since the majority of patients with exacerbations of disease were promptly treated with corticoid and azathioprine, the preceding data based on clinical activity include the effects of therapy. A rapid fall in percent T cells accompanied by rise in B-cell proportion was however seen in one SLE patient receiving no immunosuppressive drugs and who was observed during the development of an acute exacerbation of multisystem disease. This patient is illustrated in Fig. 4 (L. N.) . These data are important since they indicate that rapid changes in proportions of peripheral blood T 15 .3% with the CLL cell panel reflecting relative T-cell specificity previously noted (17) . No correlation was noted between percent or absolute numbers of T and B cells and the cytotoxic index with the normal or CLL cell panels. When the absolute number of T cells by anti-Tcell serum was compared with the cytotoxic index of that sample for the T-cell panel, a trend towards an inverse correlation was noted; however, the correlation did not reach statistical significance (r = 0.29827 P < 0.10).
Previously, we noted that in many patients with RA, the sum of percent T and B cells did not add up to 100 (21) . This (21) . At the time this study was designed this was thought to represent a rare exception to the one lymphocyte, one class of surface immunoglobulin rule. Examination of lymphocytes from patients in this current series with rhodamine-labeled anti-IgG and fluorescein-labeled antiIgA or IgM revealed however that some double labeling did indeed occur in SLE. The mean percent of doublelabeled cells found in 10 SLE patients with 24.6+18.5 whereas that for nine normal controls was 31.3±6.9. The percent of lymphocytes labeling for both IgG and IgA or IgM in the SLE patients was not significantly different from that found in normal individuals. In addition, the percent of double-labeled cells did not appear to increase as the total number of Ig-bearing cells increased.
To evaluate the possibility that the increase in percent surface Ig-bearing cells might be due to coating of T cells with antilymphocyte antibody, 33 SLE sera were incubated with normal human lymphocytes for 30 min at 370C, washed twice in Hanks balanced salt solution, and stained for surface Ig using a pool of equal parts anti-IgG, anti-IgM, and anti-IgA sera. The 33 sera included 16 with cytotoxic indices greater than 50% with the T-cell panel, and representatives from blood samples showing high, normal, and low percentages of surface Ig-bearing lymphocytes. Significant elevation of the percent of cells positive for surface Ig was seen after incubation with only three sera. Two of these three had cytotoxic indices over 50% with the T-cell panel but none were from samples in which a markedly increased percent surface Ig-bearing cells had been found. A second approach to this problem involved culture of lymphocytes from 10 patients with SLE for 48-120 h to allow for "shedding" of any adsorbed antilymphocyte anti- (18, 19, 33, 34) . In the latter instances, some degree of correlation has been shown between the diminution of peripheral bMood T cells and the presence of lymphocytotoxic antibody. Although the hypothesis that the lymphocytotoxic antibodies found in SLE are in part responsible for the depression in T cells is attractive, a convincing correlation between T cells and the cytotoxic index of the SLE sera with the panels of normal, T-cell, or CLL lymphocytes was not noted in this study. It may be that circulating lymphocytotoxic antibodies in SLE represent residual antibody molecules of low avidity and that high affinity T-cell-specific lymphocytotoxins have already been adsorbed to circulating T cells and have cleared them to the reticuloendothelial system. B-cell alterations. With respect to circulating lymphocytes bearing surface Ig, it seemed clear both from our summary data (Table II) as well as serial studies among individual patients that proportions of circulating cells bearing surface immunoglobulins were often increased and that increases frequently correlated with increased disease activity. In absolute terms the number of surface Ig-bearing lymphocytes was found to be decreased but (43) as well as a depression of T-cell suppressor activity. Infection of T cells might also render them abnormal in such a manner as to incite the formation of T-cell-specific lymphocytotoxic antibody that in turn might lead to their destruction or alter their functional activity (36, 44) . Considerably more data are necessary before the complete significance of changes in lymphocyte cell surface markers can be understood. It is hoped that the initial findings presented here may provide an impetus for others working in this area to focus study on the dynamics of T and B lymphocytes and their subpopulations in patients afflicted with connective tissue diseases.
